UniProt ID | KAT3_HUMAN | |
---|---|---|
UniProt AC | Q6YP21 | |
Protein Name | Kynurenine--oxoglutarate transaminase 3 | |
Gene Name | KYAT3 {ECO:0000312|HGNC:HGNC:33238} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 454 | |
Subcellular Localization | ||
Protein Description | Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). May catalyze the beta-elimination of S-conjugates and Se-conjugates of L-(seleno)cysteine, resulting in the cleavage of the C-S or C-Se bond (By similarity). Has transaminase activity towards L-kynurenine, tryptophan, phenylalanine, serine, cysteine, methionine, histidine, glutamine and asparagine with glyoxylate as an amino group acceptor (in vitro). Has lower activity with 2-oxoglutarate as amino group acceptor (in vitro) (By similarity).. | |
Protein Sequence | MFLAQRSLCSLSGRAKFLKTISSSKILGFSTSAKMSLKFTNAKRIEGLDSNVWIEFTKLAADPSVVNLGQGFPDISPPTYVKEELSKIAAIDSLNQYTRGFGHPSLVKALSYLYEKLYQKQIDSNKEILVTVGAYGSLFNTIQALIDEGDEVILIVPFYDCYEPMVRMAGATPVFIPLRSKPVYGKRWSSSDWTLDPQELESKFNSKTKAIILNTPHNPLGKVYNREELQVIADLCIKYDTLCISDEVYEWLVYSGNKHLKIATFPGMWERTITIGSAGKTFSVTGWKLGWSIGPNHLIKHLQTVQQNTIYTCATPLQEALAQAFWIDIKRMDDPECYFNSLPKELEVKRDRMVRLLESVGLKPIVPDGGYFIIADVSLLDPDLSDMKNNEPYDYKFVKWMTKHKKLSAIPVSAFCNSETKSQFEKFVRFCFIKKDSTLDAAEEIIKAWSVQKS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 3) | Acetylation | - | 8.55 | 22814378 | |
7 | Phosphorylation | -MFLAQRSLCSLSGR -CCCHHHHHHHHCCH | 22.96 | 25599653 | |
10 | Phosphorylation | LAQRSLCSLSGRAKF CHHHHHHHHCCHHHH | 30.75 | 25599653 | |
12 | Phosphorylation | QRSLCSLSGRAKFLK HHHHHHHCCHHHHHH | 15.22 | 18491316 | |
22 | Phosphorylation | AKFLKTISSSKILGF HHHHHHHCCCCCCCC | 33.52 | 30631047 | |
24 | Phosphorylation | FLKTISSSKILGFST HHHHHCCCCCCCCCC | 19.54 | - | |
32 | Phosphorylation | KILGFSTSAKMSLKF CCCCCCCCCCEEEEE | 25.37 | 30631047 | |
38 | Methylation | TSAKMSLKFTNAKRI CCCCEEEEECCCCEE | 42.72 | - | |
74 | Ubiquitination | NLGQGFPDISPPTYV ECCCCCCCCCCCHHH | 52.30 | 21890473 | |
74 | Acetylation | NLGQGFPDISPPTYV ECCCCCCCCCCCHHH | 52.30 | 19608861 | |
74 | Ubiquitination | NLGQGFPDISPPTYV ECCCCCCCCCCCHHH | 52.30 | 19608861 | |
76 | Phosphorylation | GQGFPDISPPTYVKE CCCCCCCCCCHHHHH | 32.01 | 26657352 | |
79 | Phosphorylation | FPDISPPTYVKEELS CCCCCCCHHHHHHHH | 44.31 | 27251275 | |
80 | Phosphorylation | PDISPPTYVKEELSK CCCCCCHHHHHHHHH | 18.46 | 27251275 | |
82 | Acetylation | ISPPTYVKEELSKIA CCCCHHHHHHHHHHH | 34.75 | 19608861 | |
82 (in isoform 1) | Ubiquitination | - | 34.75 | 21890473 | |
82 | Ubiquitination | ISPPTYVKEELSKIA CCCCHHHHHHHHHHH | 34.75 | 21906983 | |
82 (in isoform 2) | Ubiquitination | - | 34.75 | 21890473 | |
86 | Phosphorylation | TYVKEELSKIAAIDS HHHHHHHHHHHHHHH | 25.87 | 24076635 | |
87 (in isoform 2) | Ubiquitination | - | 49.33 | 21890473 | |
87 (in isoform 1) | Ubiquitination | - | 49.33 | 21890473 | |
87 | Ubiquitination | YVKEELSKIAAIDSL HHHHHHHHHHHHHHH | 49.33 | 21906983 | |
93 | Phosphorylation | SKIAAIDSLNQYTRG HHHHHHHHHHHHCCC | 24.09 | 28857561 | |
99 | Methylation | DSLNQYTRGFGHPSL HHHHHHCCCCCCHHH | 33.24 | - | |
108 (in isoform 2) | Ubiquitination | - | 49.23 | 21890473 | |
108 (in isoform 1) | Ubiquitination | - | 49.23 | 21890473 | |
108 | Ubiquitination | FGHPSLVKALSYLYE CCCHHHHHHHHHHHH | 49.23 | 21890473 | |
108 | Acetylation | FGHPSLVKALSYLYE CCCHHHHHHHHHHHH | 49.23 | 19608861 | |
116 | Succinylation | ALSYLYEKLYQKQID HHHHHHHHHHHHHCC | 38.65 | - | |
116 | Succinylation | ALSYLYEKLYQKQID HHHHHHHHHHHHHCC | 38.65 | - | |
116 | Acetylation | ALSYLYEKLYQKQID HHHHHHHHHHHHHCC | 38.65 | 19608861 | |
120 (in isoform 1) | Ubiquitination | - | 35.35 | 21890473 | |
120 (in isoform 2) | Ubiquitination | - | 35.35 | 21890473 | |
120 | Ubiquitination | LYEKLYQKQIDSNKE HHHHHHHHHCCCCCC | 35.35 | 21906983 | |
189 | Phosphorylation | PVYGKRWSSSDWTLD CCCCCCCCCCCCCCC | 24.81 | 28450419 | |
190 | Phosphorylation | VYGKRWSSSDWTLDP CCCCCCCCCCCCCCH | 25.92 | 28450419 | |
191 | Phosphorylation | YGKRWSSSDWTLDPQ CCCCCCCCCCCCCHH | 31.48 | 28450419 | |
194 | Phosphorylation | RWSSSDWTLDPQELE CCCCCCCCCCHHHHH | 26.69 | 28450419 | |
203 | Ubiquitination | DPQELESKFNSKTKA CHHHHHHHHCCCCEE | 38.91 | 21906983 | |
203 (in isoform 1) | Ubiquitination | - | 38.91 | 21890473 | |
215 | Phosphorylation | TKAIILNTPHNPLGK CEEEEECCCCCCCCC | 23.60 | - | |
222 | Ubiquitination | TPHNPLGKVYNREEL CCCCCCCCCCCHHHH | 49.59 | - | |
280 | Other | ITIGSAGKTFSVTGW EEEECCCCEEEEEEE | 46.22 | - | |
280 | N6-(pyridoxal phosphate)lysine | ITIGSAGKTFSVTGW EEEECCCCEEEEEEE | 46.22 | - | |
396 | Ubiquitination | NNEPYDYKFVKWMTK CCCCCCHHHHHHHHH | 40.56 | - | |
396 | Acetylation | NNEPYDYKFVKWMTK CCCCCCHHHHHHHHH | 40.56 | 27452117 | |
399 | Ubiquitination | PYDYKFVKWMTKHKK CCCHHHHHHHHHCCC | 34.09 | - | |
399 | Acetylation | PYDYKFVKWMTKHKK CCCHHHHHHHHHCCC | 34.09 | 25953088 | |
406 | Ubiquitination | KWMTKHKKLSAIPVS HHHHHCCCCCCCCHH | 47.60 | - | |
413 | Ubiquitination | KLSAIPVSAFCNSET CCCCCCHHHHCCCCC | 15.41 | 21890473 | |
421 | Ubiquitination | AFCNSETKSQFEKFV HHCCCCCHHHHHHHH | 37.90 | - | |
434 | Ubiquitination | FVRFCFIKKDSTLDA HHHHHHCCCCCHHHH | 30.21 | - | |
435 | Ubiquitination | VRFCFIKKDSTLDAA HHHHHCCCCCHHHHH | 52.69 | - | |
437 | Phosphorylation | FCFIKKDSTLDAAEE HHHCCCCCHHHHHHH | 39.49 | 22210691 | |
447 (in isoform 1) | Ubiquitination | - | 49.84 | 21890473 | |
447 | Ubiquitination | DAAEEIIKAWSVQKS HHHHHHHHHHHHCCC | 49.84 | 21890473 | |
453 | Ubiquitination | IKAWSVQKS------ HHHHHHCCC------ | 56.85 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KAT3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KAT3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KAT3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MSS4_HUMAN | RABIF | physical | 16169070 | |
PGM1_HUMAN | PGM1 | physical | 26344197 | |
PGM5_HUMAN | PGM5 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-108 AND LYS-116, AND MASSSPECTROMETRY. |